Yoshihiro Kawaguchi
Gifu-shi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and safety of eribulin mesylate vs. docetaxel or paclitaxel, combined with trastuzumab and pertuzumab, as first-line treatment for HER2-positive locally advanced or metastatic breast cancer: updated subgroup analyses of JBCRG-M06/EMERALD.
Journal: Breast cancer research and treatment
Published: December 26, 2025
Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.
Journal: Journal of Cancer
Published: June 14, 2023
Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04).
Journal: Breast cancer (Tokyo, Japan)
Published: August 19, 2022
Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study.
Journal: Breast cancer : basic and clinical research
Published: February 17, 2018
Preoperative neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer: a multicenter phase II trial.
Journal: Breast cancer (Tokyo, Japan)
Published: July 15, 2016
Sentinel lymph node biopsy under local anaesthesia for outpatient
Journal: Nihon rinsho. Japanese journal of clinical medicine
Published: January 29, 2013
Growth effect of neutrophil elastase on breast cancer: favorable action of sivelestat and application to anti-HER2 therapy.
Journal: Anticancer research
Published: January 04, 2012
Development of fast dissolving oral film containing dexamethasone as an antiemetic medication: clinical usefulness.
Journal: International journal of pharmaceutics
Published: November 06, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026